<DOC>
	<DOCNO>NCT00551187</DOCNO>
	<brief_summary>The purpose study evaluate vaccine immunogenicity well body tolerate V504 give Gardasil .</brief_summary>
	<brief_title>A Study Evaluate Tolerability Immunogenicity V504 Administered Concomitantly With GARDASIL ( V504-001 ) ( COMPLETED )</brief_title>
	<detailed_description />
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Vulvar Neoplasms</mesh_term>
	<mesh_term>Papillomavirus Infections</mesh_term>
	<mesh_term>Condylomata Acuminata</mesh_term>
	<mesh_term>Vaginal Neoplasms</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Females 16 26yearsold Has never Pap test normal Pap test result . Lifetime history 0 4 sexual partner History abnormal cervical biopsy result History positive test HPV ; History external genital/vaginal wart Currently user illegal drug alcohol abuser History severe allergic reaction require medical attention Are pregnant Received market HPV vaccine Currently enrol clinical trial Currently history certain medical condition currently take take certain medication ( detail discuss time consent )</criteria>
	<gender>Female</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>26 Years</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>